The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol
Lana M. Chahine,Naomi Louie,J Solle,Fulya Akçimen,Andrew Ameri,Samantha Augenbraun,Sabrina Avripas,Sarah Breaux,Christopher Causey,Shivika Chandra,Marissa Dean,Elizabeth A. Disbrow,Lauren Fanty,Jessica Fernandez,Erin R. Foster,Erin Furr Stimming,Deborah Hall,Vanessa Hinson,Ashani Johnson-Turbes,Cabell Jonas,Camilla Kilbane,Scott A. Norris,Bao-Tran Nguyen,Mahesh Padmanaban,Kimberly Paquette,Carly Parry,Natalia Pessoa Rocha,Ashley Rawls,Ejaz A. Shamim,Lisa M. Shulman,Rebeka Sipma,Julia Staisch,Rami Traurig,Rainer von Coelln,Peter Wild Crea,Tao Xie,Zih-Hua Fang,Alyssa O’Grady,Catherine M. Kopil,Maggie McGuire Kuhl,Andrew Singleton,Cornelis Blauwendraat,Sara Bandres-Ciga,the BLAAC PD Study and the Global Parkinson's Genetics Program (GP2),Maggie McGuire Kuhl,Catherine M. Kopil,Marissa Dean,Isabel Alfradique-Dunham,Juliana Coleman,Mohamed Elkasaby,Vijayakumar Javalkar,Roger Kelley,David Standaert,Tracy Tholanikunnel,Jamie Toms,Lynae Baskin,Myeshia Bean,Aidan Bonano,Brian Chauppetta,Candace Cromer,Nicolle Crovetto,Kandace Davis,Mariah Delaune,Jennifer Flowers,Randy Foli,Tenisha Franklin,Hanna Guilluly,Christina Griffin,Ashley Hawkins,Jennifer Heliste,Joshua Hines,Jessica Hudson,Nathan Krinickas,Elsa Levenes,Sophia Marathonitis,Crystal Mercado,Maysen Mesaros,James Ryan Parker,Davina Patel,Alexandra Peters,Joseph Richardson,Kyle Rizer,Christina Robinson,Andrea Rosado Chamorro,Marc Rosenbaum,Lauren Ruffrage,Kailey Sajewski,Terrelle Senette,Jenna Smith,Van Smith,Eileen Terrell,Dominique Thomas,Hannah Thomas,Kristin Thompson,Fermine Thomas-Dean,Olga Valdez,Jacqueline Vanegas,Magdaline Volcy,Rebecca Weimer,Mackenzie Williams,Jared Williamson,Dominique Woodhouse,Shayan Abdollah Zadegan,Melissa Kostrzebski,Christi Alessi-Fox,Karen Clark,Debbie Baker,Tanya Parker
DOI: https://doi.org/10.1186/s12883-024-03914-7
2024-10-22
BMC Neurology
Abstract:Determining the genetic contributions to Parkinson's disease (PD) across diverse ancestries is a high priority as this work can guide therapeutic development in a global setting. The genetics of PD spans the etiological risk spectrum, from rare, highly deleterious variants linked to monogenic forms with Mendelian patterns of inheritance, to common variation involved in sporadic disease. A major limitation in PD genomics research is lack of racial and ethnic diversity. Enrollment disparities have detrimental consequences on the generalizability of results and exacerbate existing inequities in care. The Black and African American Connections to Parkinson's Disease (BLAAC PD) study is part of the Global Parkinson's Genetics Program, supported by the Aligning Science Across Parkinson's initiative. The goal of the study is to investigate the genetic architecture underlying PD risk and progression in the Black and/or African American populations. This cross-sectional multicenter study in the United States has a recruitment target of up to 2,000 individuals with PD and up to 2,000 controls, all of Black and/or African American ancestry. The study design incorporates several strategies to reduce barriers to research participation. The multifaceted recruitment strategy aims to involve individuals with and without PD in various settings, emphasizing community outreach and engagement. The BLAAC PD study is an important first step toward informing understanding of the genetics of PD in a more diverse population.
clinical neurology